New weapons against inflammation: dual inhibitors of phospholipase A2 and transglutaminase.
Miele
Lucio
L
Department of Biopharmaceutical Sciences and Cancer Center, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, USA. lmiele@uic.edu
D000818:Animals; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006801:Humans; D007249:Inflammation / Q000188:drug therapy*; D008954:Models, Biological; D010455:Peptides / Q000494:pharmacology; D010741:Phospholipases A / Q000037:antagonists & inhibitors*; D054467:Phospholipases A2; D011503:Transglutaminases / Q000037:antagonists & inhibitors*
D004791:Enzyme Inhibitors; D010455:Peptides; D011503:Transglutaminases; D010741:Phospholipases A; D054467:Phospholipases A2